E613 10 (Opana 10 mg)
Generic Name: oxymorphone
Pill with imprint E613 10 is Red, Round and has been identified as Opana 10 mg. It is supplied by Endo Pharmaceuticals Inc..
Opana is used in the treatment of pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Opana 10 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for E613 10
Opana
- Generic Name
- oxymorphone
- Imprint
- E613 10
- Strength
- 10 mg
- Color
- Red
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Narcotic analgesics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Endo Pharmaceuticals Inc.
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
corn starch,
D&C Red No. 30
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 63481-0613 | Endo Pharmaceuticals Inc. |
| 35356-0380 | Lake Erie Medical and Surgical Supply (repackager) |
More about Opana (oxymorphone)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- 87 Reviews
- Drug class: narcotic analgesics
- FDA Alerts (2)
- FDA Approval History
Consumer resources
- Patient Information
- Opana (Advanced Reading)
- Opana (Oxymorphone Injection)
- Opana (Oxymorphone Tablets)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.